---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-307773"
form_type: "8-K"
ticker: "SPRY"
cik: "0001671858"
company_name: "ARS Pharmaceuticals, Inc."
filed_at: "2026-07-17T20:02:07+00:00"
generated_at: "2026-07-17T20:03:05.555964+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ARS Pharma board member Lowenthal resigns; CMO Tanimoto terminated without cause

## Summary
- Richard Lowenthal resigned from the Board effective July 15, 2026, as a condition for severance.
- CMO Sarina Tanimoto ceased employment on July 15, 2026, under termination without cause.
- Lowenthal receives $217,350 and Tanimoto $111,780 as prorated 2026 target bonus payments.
- Severance and bonus payments conditioned on execution of release of claims.

## SEC filing metadata
- accession: 0001193125-26-307773
- form_type: 8-K
- ticker: SPRY
- cik: 0001671858
- company_name: ARS Pharmaceuticals, Inc.
- filed_at: 2026-07-17T20:02:07+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671858/000119312526307773/0001193125-26-307773-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671858/000119312526307773/d168709d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-307773
- JSON: https://secwatch.observer/filing/0001193125-26-307773.json
- Plain text: https://secwatch.observer/filing/0001193125-26-307773.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.